The potential impact of hematocrit correction on evaluation of tacrolimus target exposure in pediatric kidney transplant patients
Open Access
- 30 October 2018
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 34 (3) , 507-515
Abstract
Tacrolimus is an important immunosuppressive agent with high intra- and inter-individual pharmacokinetic variability and a narrow therapeutic index. As tacrolimus extensively accumulates in erythrocytes, hematocrit is a key factor in the interpretation of tacrolimus whole blood concentrations. However, as hematocrit values in pediatric kidney transplant patients are highly variable after kidney transplantation, translating whole blood concentration targets without taking hematocrit into consideration is theoretically incorrect. The aim of this study is to evaluate the potential impact of hematocrit correction on tacrolimus target exposure in pediatric kidney transplant patients.Keywords
Funding Information
- Radboud University Medical Center
This publication has 36 references indexed in Scilit:
- A preliminary study searching for the right dose of tacrolimus in very young (≤4 years) renal transplant patientsJournal of Pharmacy and Pharmacology, 2016
- Anemia in children following renal transplantation—results from the ESPN/ERA-EDTA RegistryPediatric Nephrology, 2015
- Tacrolimus therapeutic drug monitoring and pediatric renal transplant graft outcomesPediatric Transplantation, 2014
- Pharmacokinetics of Tacrolimus During PregnancyTherapeutic Drug Monitoring, 2012
- Population Pharmacokinetics and Pharmacogenetics of Everolimus in Renal Transplant PatientsClinical Pharmacokinetics, 2012
- Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant RecipientsClinical Pharmacokinetics, 2009
- Therapeutic Monitoring of Calcineurin Inhibitors for the NephrologistClinical Journal of the American Society of Nephrology, 2007
- Factors affecting variability in distribution of tacrolimus in liver transplant recipientsBritish Journal of Clinical Pharmacology, 2004
- Factors Affecting the Pharmacokinetics of Tacrolimus in the First Year After Renal TransplantationTransplantation Proceedings, 1998
- Plasma Protein Binding of Tacrolimus in HumansJournal of Pharmaceutical Sciences, 1993